Oshimi K - Search Results

1

Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome.

Okamoto M, Yamaguchi H, Isobe Y, Yokose N, Mizuki T, Tajika K, Gomi S, Hamaguchi H, Inokuchi K, Oshimi K, Dan K. Okamoto M, et al. Among authors: oshimi k. Intern Med. 2009;48(10):775-81. doi: 10.2169/internalmedicine.48.1677. Epub 2009 May 15. Intern Med. 2009. PMID: 19443971 Free article.

2

Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study.

Tamai H, Yamaguchi H, Hamaguchi H, Yagasaki F, Bessho M, Kobayashi T, Akiyama H, Sakamaki H, Takahashi S, Tojo A, Ohmine K, Ozawa K, Okumura H, Nakao S, Arai A, Miura O, Toyota S, Gomi S, Murai Y, Usui N, Miyazawa K, Ohyashiki K, Takahashi N, Sawada K, Kato A, Oshimi K, Inokuchi K, Dan K. Tamai H, et al. Among authors: oshimi k. Int J Hematol. 2008 Mar;87(2):195-202. doi: 10.1007/s12185-008-0034-2. Epub 2008 Feb 6. Int J Hematol. 2008. PMID: 18253706

3

Progressive respiratory distress in a patient with splenic marginal zone lymphoma.

Masuda A, Isobe Y, Sugimoto K, Ando J, Oshimi K. Masuda A, et al. Among authors: oshimi k. Intern Med. 2008;47(13):1281-2. doi: 10.2169/internalmedicine.47.0957. Epub 2008 Jul 1. Intern Med. 2008. PMID: 18591858 Free article. No abstract available.

4

Disseminated Mucor infection and thrombotic microangiopathy in lymphoma-associated hemophagocytic syndrome.

Inagaki N, Sugimoto K, Hosone M, Isobe Y, Yamamoto Y, Sasaki M, Kato A, Mori T, Oshimi K. Inagaki N, et al. Among authors: oshimi k. Int J Hematol. 2008 Oct;88(3):355-356. doi: 10.1007/s12185-008-0156-6. Epub 2008 Sep 6. Int J Hematol. 2008. PMID: 18773259 No abstract available.

5

Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.

Isobe Y, Sugimoto K, Masuda A, Hamano Y, Oshimi K. Isobe Y, et al. Among authors: oshimi k. Intern Med J. 2009 Jun;39(6):408-11. doi: 10.1111/j.1445-5994.2009.01947.x. Intern Med J. 2009. PMID: 19580620 Review.

6

[White cell aplasia].

Isobe Y, Oshimi K. Isobe Y, et al. Among authors: oshimi k. Ryoikibetsu Shokogun Shirizu. 2000;(31):140-2. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269038 Review. Japanese. No abstract available.

7

Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.

Isobe Y, Sugimoto K, Shiraki Y, Nishitani M, Koike K, Oshimi K. Isobe Y, et al. Among authors: oshimi k. Am J Hematol. 2004 Dec;77(4):370-3. doi: 10.1002/ajh.20200. Am J Hematol. 2004. PMID: 15558805 Free article.

8

[Diffuse large B-cell lymphoma expressing surface immunoglobulin heavy chain (Ig alpha) and lacking light chains].

Ando M, Isobe Y, Sasaki M, Sugimoto K, Ando J, Oshimi K. Ando M, et al. Among authors: oshimi k. Rinsho Ketsueki. 2005 Jul;46(7):492-5. Rinsho Ketsueki. 2005. PMID: 16440740 Japanese.

9

Neural cell adhesion molecule (CD56)-positive B-cell lymphoma.

Isobe Y, Sugimoto K, Takeuchi K, Ando J, Masuda A, Mori T, Oshimi K. Isobe Y, et al. Among authors: oshimi k. Eur J Haematol. 2007 Aug;79(2):166-9. doi: 10.1111/j.1600-0609.2007.00893.x. Eur J Haematol. 2007. PMID: 17635242

10

Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.

Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators. Tauchi T, et al. Among authors: oshimi k. Leuk Res. 2011 May;35(5):585-90. doi: 10.1016/j.leukres.2010.10.027. Epub 2010 Dec 10. Leuk Res. 2011. PMID: 21145591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page